
@article{Jung,
    author    = "Sin-Ho Jung and Yaiyeong Lee and KyungMann Kim and Stephen L. George",
    title     = "Admissible two-stage designs for phase II cancer clinical trials",
    year      = "2004",
    journal	  = "Statistics In Medicine",
	volume    = "23",
	pages     = "561-569"
}


@article{Koyama,
    author  = "Tatsuki Koyama and Heidi Chen",
    title   = "Proper inference from Simon's two-stage designs",
    year    = "2008",
    journal = "Statistics In Medicine",
    volume  = "27",
    pages   = "3145-3154"
}

@article{Porcher, 
	author  = "Raphael Porcher and Kristell Desseaux",
	title   = "What inference for two stage phase {II} trials?",
	year    = "2012",
	journal = "BMC Medical Research Methodology",
	volume  = "12",
	pages   = "117" 
}

@article{Simon,
	author  = "Richard Simon",
	title   = "Optimal Two-Stage Designs for Phase II Clinical Trials",
	year    = "1989",
	journal = "Controlled Clinical Trials",
	volume  = "10",
	pages   = "1-10"
}

@article{Zhao, 
	author   = "Junjun Zhao and Menggang Yu and Xi-Ping Feng",
	title    = "Statistical inference for extended or shortened phase II studies based on Simon's two-stage designs",
	year     = "2015",
	journal  = "BMC Medical Research Methodology",
	volume   = "15",
	pages    = "48"
}


@article{Ayers,
	author  = "Dan Ayers and Jeffrey Blume",
}

@article{BlumeNotes,
  author  = "Jeffrey Blume",
  title   = "Personal Communication",
  year    = "Spring 2016"
}

@article{Blume08,
    author   = "Jeffrey Blume",
    title    = "How Often Likelihood Ratios are Misleading in Sequential Trials",
    journal  = "Communications in Statistics - Theory and Methods",
    volume   = "37",
    number   = "8",
    pages    = "1193-1206",
    year     = "2008"
}

@article{Chen,
  author  = "T Chen and T Ng",
  title   = "Optimal flexible designs in phase II clinical trials",
  year    = "1998",
  journal = "Statistics in Medicine",
  volume  = "17",
  pages   = "2301-2312"
}

@article{Green,
  author   = "SJ Green and S Dahlberg",
  title     = "Planned versus attained design in phase II clinical trials",
  year      = "1992",
  journal   = "Statistics in Medicine",
  volume    = "11",
  pages     = "853-862"
}

@article{Li,
  author   = "Yimei Li and Rosemarie Mick and Daniel Heitjan",
  title     = "A Bayesian approach for unplanned sample sizes in phase II clinical trials",
  year      = "2012",
  journal   = "Clinical Trials",
  volume    = "9",
  pages     = "293-302"
}

@article{Chang,
  author   = "M Chang and Y Li and Q An",
  title     = "Alternative designs for phase II clinical trials when attained sample sizes are different from planned sample sizes",
  year      = "2015",
  journal   = "Biometrics and Biostatistics",
  volume    = "6",
  pages     = "229"
}

@article{Simon2,
	author  = "Richard Simon",
	title   = "How large should a phase II trial of a new drug be?",
	year    = "1987",
	journal = "Cancer Treatment Reports",
	volume  = "71",
	pages   = "1079-1085"
}

@article{Paul,
  author = "Paul A. Murtaugh",
  title  = "In defense of p-values",
  year   = "2014",
  journal = "Ecology",
  volume  = "95",
  pages   = "617-621"
}

@article{Zeng,
  author = "Donglin Zeng and Fei Gao and Kuolung Hu and Catherine Jia and Joseph Ibrahim",
  title  = "Hypothesis testing for two-stage designs with over or under enrollment",
  year   = "2015",
  journal = "Statistics in Medicine",
  volume  = "34",
  pages   = "2417-2426"
}


